(CIDRAP News) Federal health officials revealed this week that they are working on a plan to use immune globulin derived from the blood of anthrax-vaccinated military personnel for emergency treatment of patients with severe cases of inhalational anthrax, if needed.
(CIDRAP News) – A new nuclear medicine technique using a radioisotope-labeled antibody has shown enough promise for early diagnosis of anthrax infection to gain the Food and Drug Administration's approval for a clinical trial, according to a recent report in the Journal of Nuclear Medicine.
(CIDRAP News) Experience suggests that public health authorities should treat the public as a key partner in responding to bioterrorist attacks, rather than as a potential source of panic and chaos, say two commentators writing in the Jan 15 issue of Clinical Infectious Diseases.
Jan 2, 2001 (CIDRAP News) Aside from Capitol Hill staff members, only 52 of more than 3,500 people who have been offered the anthrax vaccine because of the recent mail attacks have decided to take it, according to the Centers for Disease Control and Prevention (CDC).
(CIDRAP News) The Food and Drug Administration (FDA) has completed a new inspection of BioPort Corp., the only US manufacturer of the anthrax vaccine, and a company official is predicting approval of the facility after a few remaining concerns are ironed out.
(CIDRAP News) Because of a small theoretical risk that anthrax spores can hide in the lungs for up to 100 days and grow after antibiotic treatment is stopped, the anthrax vaccine and an extension of antibiotic treatment will be offered to people who may have been exposed in the recent anthrax attacks, federal health officials announced yesterday afternoon.
(CIDRAP News) The Centers for Disease Control and Prevention's (CDC's) priorities for research on anthrax include development of an antitoxin, aerosolization of anthrax powders sent by mail, and postexposure prophylaxis, CDC officials said this week.
(CIDRAP News) The US Department of Health and Human Services (HHS) has announced seven new research grant programs to speed efforts to prevent, diagnose, and treat diseases related to bioterrorism.
(CIDRAP News) Rapid tests for detecting anthrax spores on surfaces should not be used alone as the basis for public health or clinical decisions, the Centers for Disease Control and Prevention warned in today's issue of Morbidity and Mortality Weekly Report.
(CIDRAP News) Eighty-five million pieces of mail were processed at anthrax-contaminated Postal Service plants in New Jersey and Washington, DC, before the plants were closed, the Centers for Disease Control and Prevented (CDC) reported today. Although the numbers suggest that cross-contaminated mail may be widespread, officials said the risk of contracting inhalational anthrax from such mail is very low.
